MitoQ and exercise: a new hope for Long-COVID recovery in older veterans?

NCT ID NCT05373043

Recruiting now Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study is testing whether a dietary supplement called MitoQ, combined with exercise rehabilitation, can improve blood vessel function in older adults (50+) suffering from long-COVID. The trial will enroll 300 participants, including both long-COVID patients and those who have recovered from COVID-19. The goal is to see if this approach can reduce the long-term health consequences of the infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mitoquinone (MitoQ) dietary supplement
What this could lead to: If successful, this could point toward a practical, low-cost combination of a supplement and exercise to help older adults recover from long-COVID.
What could go wrong: This is a relatively small, early-stage study focused on blood vessel function, not on curing long-COVID. The supplement may not provide meaningful symptom relief, and results may not apply to younger or healthier people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LONG COVID

Contacts and locations

Locations

VA Salt Lake City Health Care System, Salt Lake City, UT
RECRUITING

Salt Lake City, Utah, 84148-0001, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.